Heidelberg Myeloma Workshop | DKG
Kollegium - St. Raphael Gymnasium in Heidelberg
Bipasha Mukhopadhyay - medical student - Burdwan Medical College | LinkedIn
ATOS Klinik Heidelberg erhält Auszeichnung für "Nachhaltiges Wirtschaften" der Stadt Heidelberg | ATOS Kliniken
JunB is a key regulator of multiple myeloma bone marrow angiogenesis | Leukemia
Heidelberg Myeloma Workshop | DKG
Studienleitgruppe – GMMG Studiengruppe
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Frontiers | CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance | Immunology
Dirk Hose, CMO
Sportliche 55.000 Euro für das KiTZ - KiTZ
Südkoreanische Krebsforscher und Politiker zu Gast am NCT Heidelberg - NCT Nationales Centrum für Tumorerkrankungen Heidelberg
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma | Leukemia
Dr. med. Hose, Innere Medizin in Heidelberg | sanego
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell ...
Myeloma Crowd Radio: Drs. Anja Seckinger and Dirk Hose, University of Heidelberg 05/24 by Myeloma Crowd Radio | Health
Full Show: New Bi-Specific Antibody Hitting Two Targets in Myeloma, Dirk Hose, MD and Anja Seckinger, MD, University of Heidelberg - The Myeloma Crowd
Full Show: New Bi-Specific Antibody Hitting Two Targets in Myeloma, Dirk Hose, MD and Anja Seckinger, MD, University of Heidelberg - The Myeloma Crowd
Stored and Cooled Ions Division - Division Members
Myeloma Crowd Radio: Drs. Anja Seckinger and Dirk Hose, University of Heidelberg 05/24 by Myeloma Crowd Radio | Health
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma - Kriegsmann - 2018 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
Press Release | Heidelberg
Das Team, das im Institut für Rechts- und Verkehrsmedizin des Universitätsklinikums Heidelberg für das QM Verantwortung
Is precision medicine a bust in myeloma? | VJHemOnc
Myeloma Crowd Radio: Drs. Anja Seckinger and Dirk Hose, University of Heidelberg 05/24 by Myeloma Crowd Radio | Health
